Post acute sequelae of COVID-19
Clinical trials for Post acute sequelae of COVID-19 explained in plain language.
Never miss a new study
Get alerted when new Post acute sequelae of COVID-19 trials appear
Sign up with your email to follow new studies for Post acute sequelae of COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a gut pill ease long COVID? new trial tests larazotide
Disease control CompletedThis Phase 2a study tests whether larazotide, a drug that tightens the gut lining, can reduce long COVID symptoms in people aged 7 to 50. Participants take the drug or a placebo four times daily for 21 days. The goal is to see if it safely improves symptoms like fatigue, brain fo…
Matched conditions: POST ACUTE SEQUELAE OF COVID-19
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can these drugs ease long COVID? new trial aims to find out
Symptom relief CompletedThis Canadian trial tested two drugs, ibudilast and pentoxifylline, against a placebo in 460 adults with lingering COVID-19 symptoms. Participants took the drugs for 2 months and were followed for 4 more months to see if symptoms improved. The goal is to find safe, effective trea…
Matched conditions: POST ACUTE SEQUELAE OF COVID-19
Phase 2/3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Simple breathing exercises show promise for long COVID breathlessness
Symptom relief CompletedThis study tested whether diaphragmatic breathing exercises can help people with Long COVID who have trouble breathing and feel tired. Sixteen adults who had COVID-19 at least four weeks earlier and still had symptoms like shortness of breath and fatigue took part. The goal was t…
Matched conditions: POST ACUTE SEQUELAE OF COVID-19
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Massive study tracks 15,000 people to unravel long COVID mysteries
Knowledge-focused CompletedThis large observational study followed over 15,000 adults in the U.S. to learn more about long COVID (Post-Acute Sequelae of SARS-CoV-2 infection). Researchers tracked symptoms, health history, and biological samples over time in both infected and uninfected people. The goal is …
Matched conditions: POST ACUTE SEQUELAE OF COVID-19
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC